Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effectiveness of Nano-hydroxyapatite Paste for Dentin Hypersensitivity
NCT02936830Phase 4Completed
- Sponsor
- Riyadh Elm University
- Start
- Oct 2016
- Primary completion
- Mar 2017
- Modality
- Hydrogel Systems, Nanoparticles, Device-based Delivery
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of nanohydroxyapatite in dentin hypersensitivity (DH) (3 arms), sponsored by Riyadh Elm University. Primary endpoint: Sensitivity measured by a visual analog scale at 1 month. Started Oct 2016; status: completed.
02
Drugs
nanohydroxyapatite
03
Conditions
dentin hypersensitivity (DH)
Beyond the preview
Go deeper on NCT02936830.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02936830.